Suppr超能文献

重新评估脾酪氨酸激酶(SYK)的激活机制。

A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.

机构信息

From the Departments of Pharmacology and.

Chemical Biology, Merck & Co., Inc., Boston, Massachusetts 02115.

出版信息

J Biol Chem. 2019 May 10;294(19):7658-7668. doi: 10.1074/jbc.RA119.008045. Epub 2019 Mar 28.

Abstract

Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain. Two prevalent models of SYK activation exist. The "OR-gate" model contends that SYK can be fully activated by phosphorylation or binding of its SH2 domains to a dual-phosphorylated immune-receptor tyrosine-based activation motif (ppITAM). An alternative model proposes that SYK activation requires ppITAM binding and phosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family tyrosine kinase (LYN). To evaluate these two models, we generated directly comparable unphosphorylated (upSYK) and phosphorylated (pSYK) proteins with or without an N-terminal glutathione -transferase (GST) tag, resulting in monomeric or obligatory dimeric SYK, respectively. We assessed the ability of a ppITAM peptide and LYN to activate these SYK proteins. The ppITAM peptide strongly activated GST-SYK but was less effective in activating upSYK untagged with GST. LYN alone activated untagged upSYK to a greater extent than did ppITAM, and inclusion of both proteins rapidly and fully activated upSYK. Using immunoblot and phosphoproteomic approaches, we correlated the kinetics and order of site-specific SYK phosphorylation. Our results are consistent with the alternative model, indicating that ppITAM binding primes SYK for rapid LYN-mediated phosphorylation of Tyr-352 and then Tyr-348 of the SH2-kinase linker, which facilitates activation loop phosphorylation and full SYK activation. This gradual activation mechanism may also explain how SYK maintains ligand-independent tonic signaling, important for B-cell development and survival.

摘要

脾酪氨酸激酶 (SYK) 是许多免疫途径中的信号节点,由两个串联的Src 同源 (SH) 2 结构域、一个 SH2-激酶连接区和一个 C 端酪氨酸激酶结构域组成。存在两种流行的 SYK 激活模型。“OR 门”模型认为,SYK 可以通过其 SH2 结构域与双磷酸化免疫受体酪氨酸基激活基序 (ppITAM) 的磷酸化或结合而被完全激活。另一种模型提出,SYK 的激活需要 ppITAM 结合以及 SRC 家族激酶(如原癌基因 LYN、SRC 家族酪氨酸激酶 (LYN))对 SH2-激酶连接区的磷酸化。为了评估这两种模型,我们生成了可直接比较的未磷酸化 (upSYK) 和磷酸化 (pSYK) 蛋白,它们带有或不带有 N 端谷胱甘肽 -S-转移酶 (GST) 标签,分别导致单体或必需的二聚体 SYK。我们评估了 ppITAM 肽和 LYN 激活这些 SYK 蛋白的能力。ppITAM 肽强烈激活 GST-SYK,但对未标记 GST 的 upSYK 的激活效果较差。LYN 单独激活未标记的 upSYK 的程度大于 ppITAM,并且两种蛋白的加入可快速且完全激活 upSYK。通过免疫印迹和磷酸化蛋白质组学方法,我们关联了特定位点 SYK 磷酸化的动力学和顺序。我们的结果与替代模型一致,表明 ppITAM 结合为 LYN 介导的 SH2-激酶连接区 Tyr-352 和 Tyr-348 的快速磷酸化做好准备,然后促进激活环磷酸化和完全的 SYK 激活。这种逐渐的激活机制也可以解释 SYK 如何维持配体非依赖性的持续信号,这对 B 细胞的发育和存活很重要。

相似文献

1
A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.重新评估脾酪氨酸激酶(SYK)的激活机制。
J Biol Chem. 2019 May 10;294(19):7658-7668. doi: 10.1074/jbc.RA119.008045. Epub 2019 Mar 28.

引用本文的文献

本文引用的文献

2
Getting Syk: spleen tyrosine kinase as a therapeutic target.靶向 Syk:脾酪氨酸激酶作为治疗靶点。
Trends Pharmacol Sci. 2014 Aug;35(8):414-22. doi: 10.1016/j.tips.2014.05.007. Epub 2014 Jun 26.
3
Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 - 2013.脾酪氨酸激酶抑制剂:2010-2013 年专利文献综述。
Expert Opin Ther Pat. 2014 May;24(5):573-95. doi: 10.1517/13543776.2014.890184. Epub 2014 Feb 20.
5
Structural and biophysical characterization of the Syk activation switch.Syk 激活开关的结构和生物物理特性分析。
J Mol Biol. 2013 Jan 23;425(2):309-33. doi: 10.1016/j.jmb.2012.11.007. Epub 2012 Nov 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验